Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Top Stories > Russian vaccine tourism catches on after Sputnik V hits WHO snag
    Top Stories

    Russian vaccine tourism catches on after Sputnik V hits WHO snag

    Published by maria gbaf

    Posted on September 23, 2021

    3 min read

    Last updated: February 2, 2026

    Image depicting travelers booking tours in Russia to receive WHO-approved COVID-19 vaccines abroad, reflecting the rising demand for vaccine tourism after Sputnik V's approval issues.
    Travelers in Russia seeking vaccine tourism for foreign COVID-19 shots - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Quick Summary

    Russians are traveling abroad for WHO-approved vaccines due to Sputnik V's approval delays, with Serbia and Germany as popular destinations.

    Russian Vaccine Tourism Grows After Sputnik V Approval Delay

    MOSCOW (Reuters) – Russian travel agencies are selling package tours for Russians to receive foreign COVID-19 vaccines abroad amid frustration among some Russians that their domestically produced vaccines have not been approved internationally.

    Russia has not registered any foreign-made vaccines for use. It has approved four domestically produced vaccines including the two-dose Sputnik V. None of Russia’s shots are approved by the World Health Organisation or European Union.

    The WHO has suspended its approval process for Sputnik V until a factory that failed a good practices inspection is visited again, the Pan American Health Organization said on Sept. 15.

    Demand in Russia for tours allowing people to receive foreign vaccines approved by the WHO has risen since that announcement last week, said Maya Lomidze, director of Russia’s Association of Tour Operators (ATOR).

    Most of the trips, costing around 600-850 euros, are to Serbia, and one firm was offering Germany as a destination. They allow customers to receive one of four different vaccines, including the one developed with Pfizer, ATOR said in a statement.

    If the travellers choose a two-dose vaccine, they need to book two trips.

    Anna Filatovskaya, the PR director of Russian Express, a travel agency offering such tours, said that clients were choosing the Pfizer shot most often.

    She said its package tours included return flights with Aeroflot, two-three nights in a hotel in Belgrade, breakfast and travel to a clinic. The vaccine shot itself is free, but the travel agency registers clients to receive it, she said.

    “We started selling these tours around two weeks ago. There were around 20 applications in that time … ” she said.

    Demand spiked on Wednesday after local media reports of the availability of such tours, she said.

    “This provoked wild demand,” she told Reuters. She said 17 people had applied for a vaccination trip on Wednesday.

    Ivetta Verdiyan, the advertising director of another travel agency, said their tours were mainly being used by Russians who travel for business or whose children study abroad.

    Maria, a Moscow resident, said she travelled abroad this summer to get vaccinated, though she did not use one of these tours.

    “I trust Sputnik – but it is not recognised outside of Russia. Travel rules in the world mean I need an international certificate to move around for work,” she said, declining to give her family name.

    (Reporting by Polina Nikolskaya; Writing by Tom Balmforth; Editing by Alison Williams)

    Key Takeaways

    • •Russian travelers seek foreign vaccines due to Sputnik V's lack of WHO approval.
    • •Vaccine tourism packages include trips to Serbia and Germany.
    • •Demand for these tours has increased following WHO's suspension of Sputnik V approval.
    • •Pfizer is the most popular vaccine choice among Russian tourists.
    • •Travel agencies report a spike in demand following media coverage.

    Frequently Asked Questions about Russian vaccine tourism catches on after Sputnik V hits WHO snag

    1What is the main topic?

    The article discusses Russian vaccine tourism due to Sputnik V's lack of WHO approval.

    2Why are Russians traveling for vaccines?

    Russians are traveling abroad to receive WHO-approved vaccines due to Sputnik V's international non-recognition.

    3Which vaccines are popular among Russian tourists?

    The Pfizer vaccine is the most popular choice among Russian tourists seeking foreign vaccination.

    More from Top Stories

    Explore more articles in the Top Stories category

    Image for Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Lessons From the Ring and the Deal Table: How Boxing Shapes Steven Nigro’s Approach to Banking and Life
    Image for Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Joe Kiani in 2025: Capital, Conviction, and a Focused Return to Innovation
    Image for Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Marco Robinson – CLOSE THE DEAL AND SUDDENLY GROW RICH
    Image for Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Digital Tracing: Turning a regulatory obligation into a commercial advantage
    Image for Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Exploring the Role of Blockchain and the Bitcoin Price Today in Education
    Image for Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Inside the World’s First Collection Industry Conglomerate: PCA Global’s Platform Strategy
    Image for Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Chase Buchanan Private Wealth Management Highlights Key Autumn 2025 Budget Takeaways for Expats
    Image for PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    PayLaju Strengthens Its Position as Malaysia’s Trusted Interest-Free Sharia-Compliant Loan Provider
    Image for A Notable Update for Employee Health Benefits:
    A Notable Update for Employee Health Benefits:
    Image for Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Creating Equity Between Walls: How Mohak Chauhan is Using Engineering, Finance, and Community Vision to Reengineer Affordable Housing
    Image for Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Upcoming Book on Real Estate Investing: Harvard Grace Capital Founder Stewart Heath’s Puts Lessons in Print
    Image for ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    ELECTIVA MARKS A LANDMARK FIRST YEAR WITH MAJOR SENIOR APPOINTMENTS AND EXPANSION MILESTONES
    View All Top Stories Posts
    Previous Top Stories PostEngland’s top medic says COVID-19 transmission highest in children
    Next Top Stories PostSoccer-Standing areas at Premier League grounds to be allowed from January